Literature DB >> 18477509

Synthesis and antitumor activity of benzils related to combretastatin A-4.

Céline Mousset1, Anne Giraud, Olivier Provot, Abdallah Hamze, Jérôme Bignon, Jian-Miao Liu, Sylviane Thoret, Joëlle Dubois, Jean-Daniel Brion, Mouâd Alami.   

Abstract

A series of benzil derivatives related to combretastatin A-4 (CA-4) have been synthesized by oxidation of diarylalkynes promoted by PdI(2) in DMSO. Using this new protocol, 14 benzils were prepared in good to excellent yields and their biological activity has been delineated. Several benzils exhibited excellent antiproliferative activity: for example, 4j and 4k bearing the greatest resemblance to CA-4 and AVE-8062, respectively, were found to inhibit cell growth at the nanomolar level (20-50nM) on four human tumor cell lines. Flow cytometric analysis indicates that these compounds act as antimitotics and arrest the cell cycle in G(2)/M phase. A cell-based assay indicated that compounds 4j and 4k displayed a similar inhibition of tubulin assembly with an IC(50) value similar to CA-4. These results clearly demonstrated that the Z-double bond of CA-4 can be replaced by a 1,2-diketone unit without significant loss of cytotoxicity and inhibition of tubulin assembly potency.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18477509     DOI: 10.1016/j.bmcl.2008.04.053

Source DB:  PubMed          Journal:  Bioorg Med Chem Lett        ISSN: 0960-894X            Impact factor:   2.823


  8 in total

1.  A novel AMPK activator reduces glucose uptake and inhibits tumor progression in a mouse xenograft model of colorectal cancer.

Authors:  Silvia Valtorta; Gabriella Nicolini; Farida Tripodi; Cristina Meregalli; Guido Cavaletti; Federica Avezza; Luca Crippa; Gloria Bertoli; Francesca Sanvito; Paola Fusi; Roberto Pagliarin; Fulvia Orsini; Rosa Maria Moresco; Paola Coccetti
Journal:  Invest New Drugs       Date:  2014-08-19       Impact factor: 3.850

2.  Synthesis and evaluation of diaryl sulfides and diaryl selenide compounds for antitubulin and cytotoxic activity.

Authors:  Edson dos A dos Santos; Ernest Hamel; Ruoli Bai; James C Burnett; Camila Santos Suniga Tozatti; Danielle Bogo; Renata T Perdomo; Alexandra M M Antunes; M Matilde Marques; Maria de F C Matos; Dênis P de Lima
Journal:  Bioorg Med Chem Lett       Date:  2013-06-12       Impact factor: 2.823

3.  2'-Chloro-4-meth-oxy-3-nitro-benzil.

Authors:  G Nithya; B Thanuja; G Chakkaravarthi; Charles C Kanagam
Journal:  Acta Crystallogr Sect E Struct Rep Online       Date:  2011-05-28

4.  3D-QSAR Study of Combretastatin A-4 Analogs Based on Molecular Docking.

Authors:  Yinghua Jin; Ping Qi; Zhiwei Wang; Qirong Shen; Jian Wang; Weige Zhang; Hongrui Song
Journal:  Molecules       Date:  2011-08-08       Impact factor: 4.411

5.  I2-Catalyzed Carbonylation of α-Methylene Ketones to Synthesize 1,2-Diaryl Diketones and Antiviral Quinoxalines in One Pot.

Authors:  Lingkai Kong; Jieru Meng; Wenyue Tian; Jiazheng Liu; Xueping Hu; Zhi-Hong Jiang; Wei Zhang; Yanzhong Li; Li-Ping Bai
Journal:  ACS Omega       Date:  2021-12-21

Review 6.  Combretastatins: An Overview of Structure, Probable Mechanisms of Action and Potential Applications.

Authors:  Gökçe Şeker Karatoprak; Esra Küpeli Akkol; Yasin Genç; Hilal Bardakci; Çiğdem Yücel; Eduardo Sobarzo-Sánchez
Journal:  Molecules       Date:  2020-05-31       Impact factor: 4.411

7.  Dark-Binding Process Relevant to Preventing Photosensitized Oxidation: Conformation-Dependent Light and Dark Mechanisms by a Dual-Functioning Diketone.

Authors:  Sarah J Belh; Niluksha Walalawela; Stas Lekhtman; Alexander Greer
Journal:  ACS Omega       Date:  2019-12-19

8.  Synthesis and characterization of novel combretastatin analogues of 1,1-diaryl vinyl sulfones, with antiproliferative potential via in-silico and in-vitro studies.

Authors:  Godshelp O Egharevba; Ahmed Kamal; Omotayo O Dosumu; Sunitha Routhu; Olatomide A Fadare; Stephen O Oguntoye; Stanislaus N Njinga; Abimbola P Oluyori
Journal:  Sci Rep       Date:  2022-02-03       Impact factor: 4.379

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.